Roche Opens Direct Response Buying Review

Share this article:
Pharmaceutical giant Roche, Nutley, NJ, has launched a review to choose an agency that will buy direct response media for its Tamiflu influenza pill.


Agencies participating in the review include Young & Rubicam's Impiric, which handles direct response buying for Tamiflu; Initiative Media's Media Direct Partners; and Media Marketing Solutions, also owned by Y&R.


AAR/Bob Wolf Partners, New York, is the advertising consultant on the review. The decision is due in October.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions